Open AccessIsolation and Molecular Characterization of Cancer Stem Cells in MMTV‐ Wnt‐1 Murine Breast Tumors
Author(s) -
Cho Robert W.,
Wang Xinhao,
Diehn Maximilian,
Shedden Kerby,
Chen Grace Y.,
Sherlock Gavin,
Gurney Austin,
Lewicki John,
Clarke Michael F.
Publication year - 2008
Publication title -
stem cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.159
H-Index - 229
eISSN - 1549-4918
pISSN - 1066-5099
DOI - 10.1634/stemcells.2007-0440
Subject(s) - biology , cancer stem cell , cd24 , breast cancer , wnt signaling pathway , cancer research , stem cell , cd44 , cancer , population , cancer cell , pathology , immunology , cell , gene , genetics , medicine , environmental health
In human breast cancers, a phenotypically distinct minority population of tumorigenic (TG) cancer cells (sometimes referred to as cancer stem cells) drives tumor growth when transplanted into immunodeficient mice. Our objective was to identify a mouse model of breast cancer stem cells that could have relevance to the study of human breast cancer. To do so, we used breast tumors of the mouse mammary tumor virus (MMTV)‐ Wnt‐1 mice. MMTV‐ Wnt‐1 breast tumors were harvested, dissociated into single‐cell suspensions, and sorted by flow cytometry on Thy1, CD24, and CD45. Sorted cells were then injected into recipient background FVB/NJ female syngeneic mice. In six of seven tumors examined, Thy1+CD24+ cancer cells, which constituted approximately 1%–4% of tumor cells, were highly enriched for cells capable of regenerating new tumors compared with cells of the tumor that did not fit this profile (“not‐Thy1+CD24+”). Resultant tumors had a phenotypic diversity similar to that of the original tumor and behaved in a similar manner when passaged. Microarray analysis comparing Thy1+CD24+ tumor cells to not‐Thy1+CD24+ cells identified a list of differentially expressed genes. Orthologs of these differentially expressed genes predicted survival of human breast cancer patients from two different study groups. These studies suggest that there is a cancer stem cell compartment in the MMTV‐ Wnt‐1 murine breast tumor and that there is a clinical utility of this model for the study of cancer stem cells. Disclosure of potential conflicts of interest is found at the end of this article.